Serum metabolomics identified specific lipid compounds which may serve as markers of disease progression in patients with Alström and Bardet-Biedl syndromes

Objectives: Alström syndrome (ALMS) and Bardet-Biedl syndrome (BBS) are among the so-called ciliopathies and are associated with the development of multiple systemic abnormalities, including early childhood obesity and progressive neurodegeneration. Given the progressive deterioration of patients’ q...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeziorny, Krzysztof, Pietrowska, Karolina, Sieminska, Julia, Zmyslowska-Polakowska, Ewa, Kretowski, Adam, Ciborowski, Michal, Zmyslowska, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657895/
https://www.ncbi.nlm.nih.gov/pubmed/38028552
http://dx.doi.org/10.3389/fmolb.2023.1251905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657895/
https://www.ncbi.nlm.nih.gov/pubmed/38028552
http://dx.doi.org/10.3389/fmolb.2023.1251905

Ejemplares similares